Close
American Drug Delivery & Formulation Summit
Xylem

News

Evotec and Lilly enter into drug discovery collaboration in metabolic diseases

Evotec SE announced today that the Company has entered into a drug discovery collaboration with Eli Lilly and Company in the field of metabolic diseases with a focus on kidney diseases and diabetes. The collaboration leverages Evotecโ€™s extensive experience and...

Ashfield Engage bolsters patient solutions offering in Canada with Medaxis acquisition

Ashfield Engage, part of UDG Healthcare, has announced the acquisition of Medaxis, a patient engagement services partner for the life sciences industry, providing services to healthcare professionals and patients. Ashfield Engage, which has a Patient Solutions offering specializing in patient...

Fermenta Biotech Limited exclusively licenses its proprietary enzymatic technology for manufacturing Molnupiravir to Aurigene Pharmaceutical

Fermenta Biotech Limitedย  announced that it has signed a Definitive Agreement with Aurigene Pharmaceutical Services Limited (APSL), a stepdown subsidiary of Dr Reddyโ€™s Laboratories Limited (DRL). In this arrangement, FBL will exclusively license its proprietary biocatalytic technology for synthesis...

Genezen appoints Senior Director of Business Development to support rapid growth

Genezen, Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) focused on early-phase process development, GMP vector production and analytical testing services, has appointed Laura Jacanin as Senior Director of Business Development. Previouslyย with similar roles at Wuxi,...

19th Edition of BioAsia to focus on Future Readiness of the Life-Sciences Industry; 2-Day event to kick-start on February 24th

19th edition of the Asiaโ€™s largest life-sciences and Health Tech forum BioAsia, the annual flagship event of Government of Telangana will be held during February 24th and 25th, 2022 in a virtual format. The theme of this yearโ€™s edition...

Vetter’s Peter Soelkner featured on the โ€œMolecule to Marketโ€ podcast

Peter Soelkner featured on the โ€œMolecule to Marketโ€ podcast Peter Soelkner, one of the managing directors at Vetter, recently sat down with Raman Sehgal of the โ€œMolecule to Marketโ€ podcast to share his personal background, the history of Vetter, and...

Indian Pharmaceutical Industry Now And In The Days To Come

It shouldnโ€™t come as a surprise when we call India a global powerhouse when it comes to generic drugs. The Indian pharmaceutical companies cater to more than 50% of world vaccination supplies as well as 40% generic demand in...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป